• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中重度特应性皮炎患儿的多媒体混合现实交互式共享决策游戏:一项试点研究

Multimedia Mixed Reality Interactive Shared Decision-Making Game in Children with Moderate to Severe Atopic Dermatitis, a Pilot Study.

作者信息

Chang Ling-Sai, Kuo Ho-Chang, Suen Jason Jyh-Bin, Yang Pei-Hsin, Hou Chiu-Ping, Sun Hui-Ru, Lee Zon-Min, Huang Ying-Hsien

机构信息

Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.

Department of Digital Media Design, I-Shou University, Kaohsiung 83301, Taiwan.

出版信息

Children (Basel). 2023 Mar 17;10(3):574. doi: 10.3390/children10030574.

DOI:10.3390/children10030574
PMID:36980133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10047264/
Abstract

(1) Objective: Atopic dermatitis (AD) is a recurring skin disease that affects children's daily activities and sleep quality. Due to the limitations of children's understanding and ability to express themselves, shared decision making (SDM) is often made by guardians, which thus affects the acceptance and effectiveness of children's treatments. Previous studies have demonstrated that involving both children and parents in decision making may help improve treatment outcomes; thus, we designed a multimedia mixed reality (MR) interactive game of SDM for children with moderate to severe AD. (2) Methods: Research participants included 6-18-year-old patients with moderate to severe AD. This research consisted of the following steps: designing SDM; character setting and visual design; performing games; system modification and optimization; screen editing and dubbing; and user testing and questionnaires by the System Usability Scale (SUS). (3) Results: We completed the SDM design for children with moderate to severe AD. Four different treatments were biologics, oral immune-modulating drugs, phototherapy, and wet wrap. An animated PowerPoint slide showed the AD apple rolling around before treatments and the AD apple sleeping soundly after treatments. Instructions with video teaching for the four different treatments were played, and then, the MR was turned on so that the patients could help the AD apple in the metaverse to undergo these four treatments. A total of 12 moderate to severe AD patients and six control patients used the game, all aged between six and eighteen years old, with an average SUS score of 81.0 and a standard error of 2.1 points. Adjective ratings yielded a rating between good and excellent. The game showed acceptable usability. We found no statistically significant differences in SUS scores between patients with and without moderate to severe AD or between boys and girls nor significant associations between SUS and age or severity. The analysis identified that the two items with the lowest SUS scores were "I think that I would need the support of a technical person to be able to use this product" and "I needed to learn a lot of things before I could get going with this product". Both of these comments show the limitations of this game. (4) Conclusions: Overall, this study provides the first MR SDM game that has passed the SUS and can be used as an aid in clinical SDM.

摘要

(1)目的:特应性皮炎(AD)是一种复发性皮肤病,会影响儿童的日常活动和睡眠质量。由于儿童理解和表达能力的限制,共同决策(SDM)通常由监护人做出,这进而影响了儿童治疗的接受度和效果。先前的研究表明,让儿童和父母都参与决策可能有助于改善治疗结果;因此,我们为中重度AD儿童设计了一款多媒体混合现实(MR)交互式共同决策游戏。(2)方法:研究参与者包括6至18岁的中重度AD患者。本研究包括以下步骤:设计共同决策;角色设定和视觉设计;进行游戏;系统修改和优化;屏幕编辑和配音;以及通过系统可用性量表(SUS)进行用户测试和问卷调查。(3)结果:我们完成了中重度AD儿童的共同决策设计。四种不同的治疗方法是生物制剂、口服免疫调节药物、光疗和湿敷。一个动画PowerPoint幻灯片展示了治疗前AD苹果四处滚动以及治疗后AD苹果安然入睡的情景。播放了针对四种不同治疗方法的视频教学说明,然后开启MR,以便患者在元宇宙中帮助AD苹果接受这四种治疗。共有12名中重度AD患者和6名对照患者使用了该游戏,所有患者年龄均在6至18岁之间,平均SUS评分为81.0,标准误差为2.1分。形容词评级得出的评价在良好到优秀之间。该游戏显示出可接受的可用性。我们发现,中重度AD患者与非中重度AD患者之间、男孩与女孩之间的SUS评分没有统计学上的显著差异,SUS与年龄或严重程度之间也没有显著关联。分析确定SUS评分最低的两个项目是“我认为我需要技术人员的支持才能使用这个产品”和“在我能够使用这个产品之前,我需要学习很多东西”。这两条评论都显示了这款游戏的局限性。(4)结论:总体而言,本研究提供了第一款通过SUS测试的MR共同决策游戏,可作为临床共同决策的辅助工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f873/10047264/72dc8107bc80/children-10-00574-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f873/10047264/561eb83e0204/children-10-00574-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f873/10047264/e3d91f629cd0/children-10-00574-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f873/10047264/72dc8107bc80/children-10-00574-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f873/10047264/561eb83e0204/children-10-00574-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f873/10047264/e3d91f629cd0/children-10-00574-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f873/10047264/72dc8107bc80/children-10-00574-g003.jpg

相似文献

1
Multimedia Mixed Reality Interactive Shared Decision-Making Game in Children with Moderate to Severe Atopic Dermatitis, a Pilot Study.中重度特应性皮炎患儿的多媒体混合现实交互式共享决策游戏:一项试点研究
Children (Basel). 2023 Mar 17;10(3):574. doi: 10.3390/children10030574.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.在一项开放性研究中,度普利尤单抗为中重度特应性皮炎成人患者提供了长达 4 年的可接受安全性和持续疗效。
Am J Clin Dermatol. 2022 May;23(3):393-408. doi: 10.1007/s40257-022-00685-0. Epub 2022 May 3.
4
Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.特应性皮炎成人患者疾病控制不佳和疾病严重程度与患者报告疾病负担的相关性。
JAMA Dermatol. 2018 Aug 1;154(8):903-912. doi: 10.1001/jamadermatol.2018.1572.
5
Physician Perception of Disease Severity and Treatment Outcomes for Children and Adolescents with Atopic Dermatitis in Emerging Economies.新兴经济体中医生对儿童和青少年特应性皮炎疾病严重程度及治疗结果的认知
Dermatol Ther (Heidelb). 2022 Apr;12(4):999-1013. doi: 10.1007/s13555-022-00708-y. Epub 2022 Mar 26.
6
Shared Decision-Making for Drug-Drug Interactions: Formative Evaluation of an Anticoagulant Drug Interaction.药物相互作用的共同决策:抗凝药物相互作用的形成性评估
JMIR Form Res. 2022 Oct 19;6(10):e40018. doi: 10.2196/40018.
7
Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis.中重度特应性皮炎成人患者中瘙痒数字评分量表、皮肤疼痛数字评分量表和特应性皮炎睡眠量表的心理测量特性。
Health Qual Life Outcomes. 2021 Oct 23;19(1):247. doi: 10.1186/s12955-021-01877-8.
8
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).度普利尤单抗治疗青少年中重度特应性皮炎的长期疗效和安全性:III 期开放标签扩展试验(LIBERTY AD PED-OLE)的第 52 周结果。
Am J Clin Dermatol. 2022 May;23(3):365-383. doi: 10.1007/s40257-022-00683-2. Epub 2022 May 14.
9
No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab.在长达 4 年的时间里,接受度普利尤单抗治疗的中重度特应性皮炎成人患者的总体感染风险没有增加。
Adv Ther. 2023 Jan;40(1):367-380. doi: 10.1007/s12325-022-02322-y. Epub 2022 Nov 1.
10
Decision aid prototype for treatment of pediatric sleep disordered breathing: A randomized pilot study.小儿睡眠呼吸障碍治疗决策辅助原型:一项随机试点研究。
Laryngoscope. 2019 Jan;129(1):229-234. doi: 10.1002/lary.27204. Epub 2018 Nov 8.

引用本文的文献

1
Perinatal Characteristics and the Sensitization to Cow Milk, Egg Whites and Wheat in Children up to 3 Years of Age.围产期特征与3岁以下儿童对牛奶、蛋清和小麦的致敏情况
Children (Basel). 2023 May 11;10(5):860. doi: 10.3390/children10050860.

本文引用的文献

1
Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design.患者相似性及其他人工智能机器学习算法在预防心血管毒性(PACT)共同决策临床决策辅助中的应用:一项可行性试验设计
Cardiooncology. 2023 Jan 23;9(1):7. doi: 10.1186/s40959-022-00151-0.
2
Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway.随机临床试验评估房颤卒中预防共享决策路径。
J Am Heart Assoc. 2023 Feb 7;12(3):e028562. doi: 10.1161/JAHA.122.028562.
3
Patients' and Caregivers' Experiences With Atopic Dermatitis-Related Burden, Medical Care, and Treatments in 8 Countries.
8个国家中患者及护理人员在特应性皮炎相关负担、医疗护理及治疗方面的经历
J Allergy Clin Immunol Pract. 2023 Jan;11(1):264-273.e1. doi: 10.1016/j.jaip.2022.10.032. Epub 2022 Nov 2.
4
Adolescents with Atopic Dermatitis Have Lower Peak Exercise Load Capacity and Exercise Volume Compared with Unaffected Peers.患有特应性皮炎的青少年与未受影响的同龄人相比,其最大运动负荷能力和运动容量较低。
Int J Environ Res Public Health. 2022 Aug 18;19(16):10285. doi: 10.3390/ijerph191610285.
5
Including the voice of paediatric patients: Cocreation of an engagement game.纳入儿科患者的声音:共创参与式游戏。
Health Expect. 2022 Aug;25(4):1861-1871. doi: 10.1111/hex.13530. Epub 2022 Jun 24.
6
Association between Serum Total and Specific Immunoglobulin E Levels and Body Height: A Cross-Sectional Study of Children and Adolescents.血清总免疫球蛋白E及特异性免疫球蛋白E水平与身高的关联:一项儿童和青少年横断面研究
Children (Basel). 2022 May 4;9(5):661. doi: 10.3390/children9050661.
7
Taiwan guidelines for the diagnosis and management of pediatric atopic dermatitis: Consensus statement of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology.台湾儿童特应性皮炎诊断与管理指南:台湾儿童过敏气喘及免疫学会共识声明。
J Microbiol Immunol Infect. 2022 Aug;55(4):561-572. doi: 10.1016/j.jmii.2022.03.004. Epub 2022 Apr 20.
8
Allergen Tests of Fruit Sensitization Involving Children with Allergic Diseases.涉及过敏性疾病儿童的水果致敏原测试
Children (Basel). 2022 Mar 28;9(4):470. doi: 10.3390/children9040470.
9
Playful strategies to foster the well-being of pediatric cancer patients in the Brazilian Unified Health System: a design thinking approach.采用游戏策略促进巴西统一卫生系统中儿科癌症患者的健康:设计思维方法。
BMC Health Serv Res. 2021 Sep 18;21(1):985. doi: 10.1186/s12913-021-07018-7.
10
DNA Methylation Array Identifies Golli-MBP as a Biomarker for Disease Severity in Childhood Atopic Dermatitis.DNA甲基化阵列鉴定出Golli-MBP作为儿童特应性皮炎疾病严重程度的生物标志物。
J Invest Dermatol. 2022 Jan;142(1):104-113. doi: 10.1016/j.jid.2021.06.025. Epub 2021 Jul 19.